Prostate Cancer International is
for 2011 by Great NonProfits
Perspective Confidentiality Disclosure Reliability Courtesy
A new study has attempted to calculate the impact of age, health status, and patient preference on the relative outcomes (and merits) of immediate surgery as compared to active surveillance for the management of low-risk prostate cancer.
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: active surveillance, life, low, outcome, quality, risk, surgery | 3 Comments »
From a health economics point of view, prostate cancer costs a lot of money every year — because a lot of men get diagnosed and treated.
Filed under: Living with Prostate Cancer, Management | Tagged: active surveillance, cost, cost-effectiveness | 3 Comments »
According to a new study published on line in Prostate Cancer and Prostatic Diseases, 370/425 urologists who responded to a recent survey felt that active surveillance was a reasonable management strategy and about 350/425 actually manage patients by using this approach. But
Filed under: Living with Prostate Cancer, Management, Uncategorized | Tagged: acceptance, active surveillance, opinion, urologist | 19 Comments »
In May last year (i.e., May 2010), the Prostate Cancer Foundation announced a partnership with Johns Hopkins and Cedars-Sinai to set up a national, proactive prostate cancer surveillance initiative. We reported this announcement … and then we heard no more.
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: active surveillance, National Proactive Surveillance Network, registry, trial | Leave a Comment »
Here — for whatever they are worth — are some musings about what (in our opinion) seems to have come out of the NIH state of the science conference on active surveillance held earlier this week. As previously noted, the initial draft consensus statement from the panel discussants can be found on line if you [...]
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: active surveillance | 17 Comments »
The official, draft, state-of-the-science statement from the National Institutes of Health conference on the role of active surveillance in the management of men with localized prostate cancer was made publicly available just a few minutes ago this morning. To read the full statement, please click here.
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: active surveillance | 12 Comments »
So the National Institutes of Health (NIH) “state of the science” conference on the role of active surveillance in the management of men with localized prostate cancer
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: active surveillance | Leave a Comment »
Many readers may be interested in an article on active surveillance and other forms of expectant management by Khurana and Stephenson that appears on the front page of the November issue of the AUA News. This article is based on a poster presented by Khurana et al. at the annual meeting of the American Urological [...]
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: active surveillance, expectant management, observation, watchful waiting | 1 Comment »
A new study in the Journal of Urology reports data on a cohort of 125 patients enrolled in the Physicians’ Health Study (PHS) who elected to be managed with watchful waiting for a minimum of 1 year after their initial diagnosis and who were followed for an average (mean) of 7.3 years.
Filed under: Management, Treatment | Tagged: active surveillance, long-term, outcome, quality of life, watchful waiting | 8 Comments »
We recommend to our readers a recent article in Medscape Oncology entitled “What’s impeding active surveillance in prostate cancer?” The article is based on a review by Cooperberg et al. in a recent issue of the Journal of Clinical Oncology. However, the full text of that review article is not easily accessible for most patients [...]
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: acceptance, active surveillance, education | 9 Comments »
Centers apply a variety of inclusion criteria in evaluating the eligibility of patients for management using active surveillance (AS) protocols. The applicability of an immediate, transrectal ultrasound (TRUS)-guided re-biopsy is recommended by a number of centers, but there is no consensus about the need for re-biopsy at this time.
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: active surveillance, biopsy, eligibility, repeat | 4 Comments »
It will likely be evident to most well-informed prostate cancer patients, support group leaders, and advocates that a man with low-risk, early stage prostate cancer (“favorable histology”) is potentially a good candidate for prostate cancer surgery.
Filed under: Diagnosis, Management, Treatment | Tagged: active surveillance, continence, outcome, quality of life, RALP, robot-assisted laparoscopic prostatectomy, sexual function | Leave a Comment »
A forthcoming paper from Tewari’s group at Weill Cornell Medical College in New York describes a new set of nomograms for assessment of risk for worsening prognosis in men with localized prostate cancer who might otherwise be considered appropriate candidates for management under active surveillance.
Filed under: Diagnosis, Management, Risk | Tagged: active surveillance, candidate, nomogram, prognosis, risk | 9 Comments »
A previously unanswered question is whether a finding of perineural invasion in the biopsy cores of men who otherwise meet all relevant criteria for management by active surveillance does or does not actually increase risk for progressive forms of prostate cancer.
Filed under: Diagnosis, Living with Prostate Cancer, Management | Tagged: active surveillance, biopsy, perineural invasion, risk | Leave a Comment »
On December 5 to 7 this year, the National Institutes of Health (NIH) is to hold an NIH State-of-the-Science Conference on the role of active surveillance and watchful waiting in the management of men with supposedly localized prostate cancer. It is free and open to the public or it can be monitored by web cast.
Filed under: Diagnosis, Management, Risk | Tagged: active surveillance, watchful waiting | Leave a Comment »
Search for new and
ongoing trials on the
CTAG PCa web site